Anti-infective Vaccines Market Report 2021-2031

·4 min read

Forecasts by Product Type (Live/Attenuated Vaccines, Inactivated Vaccines, DNA & Recombinant Vector Vaccines, Others), by Disease Type (Bacterial Diseases (Typhoid Vaccines, Tuberculosis Vaccines, Tetanus & Diphtheria Vaccines, Others), Viral Diseases (Influenza Vaccines, Hepatitis Vaccines, Polio Vaccines, Others)), by Distribution Channel (Hospitals, Clinics, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Anti-infective Vaccines Companies AND COVID-19 Recovery Scenarios

New York, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Anti-infective Vaccines Market Report 2021-2031" - https://www.reportlinker.com/p06126789/?utm_source=GNW

Growing Government Focus on Immunization Programs

The anti-infective vaccines market is predicted to develop due to a broad coalition of governments striving to raise awareness of the benefits of vaccination through immunisation programs with the goal of preventing the spread of communicable illnesses that are linked with high morbidity and mortality. For example, the ’Immunize Australia Program’ funds individual immunisation, which serves as a preventative measure in reducing illness onset and limiting illness transmission, therefore sparing millions of Australians from serious diseases. The growing significance of government and non-government organisations in this industry is likely to give the vertical a significant boost. UNICEF and the WHO have released guidelines for developing a national immunisation plan, known as the Comprehensive Multi-Year Plan (cMYP), for all countries around the world, with the goal of ensuring equitable access to vaccination facilities for all people and increasing stakeholder participation in meeting vaccination coverage targets by designing and implementing feasible financial strategies.

Which Factors are Driving the Global Anti-Infective Vaccines Market?
. Growing Vaccination Awareness to Boost Anti-Infective Vaccines Market
. Increasing Incidence of Infectious Diseases
. Rising R&D Activities to Fuel Anti-Infective Vaccines Market Growth Through 2031
. Growing Government Focus on Immunization Programs

What are the Market Opportunities for Global Anti-Infective Vaccines Market?
. Growing Government Support to Offer Lucrative Growth Prospects
. Emerging Infectious Diseases to Offer Lucrative Growth Prospects
. Increasing Vaccine Penetration Coverage

Discover how to stay ahead

Our 370+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Anti-Infective Vaccines Market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects
. In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
. You find original analyses, with business outlooks and developments.
. Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter’s Five Forces, SWOT Analysis, product profiles and commercial developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Discover sales predictions for the world market and sub-markets

Product Type
. Live/Attenuated Vaccines
. Inactivated Vaccines
. DNA & Recombinant Vector Vaccines
. Others

Disease Type
. Bacterial Diseases
- Typhoid Vaccines
- Tuberculosis Vaccines
- Tetanus & Diphtheria Vaccines
- Others
. Viral Diseases
- Influenza Vaccines
- Hepatitis Vaccines
- Polio Vaccines
- Others

Distribution Channel
. Hospitals Clinics
. Public Hospitals
. Private Clinics
. Retail Pharmacies and Drug Stores
. E-commerce

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 16 leading national markets:

By Region
. North America
- U.S.
- Canada
. Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
. Asia Pacific
- China
- Japan
- India
- Australia
- Rest of Asia Pacific
. Latin America
- Brazil
- Mexico
- Rest of Latin America
. Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa

Leading companies and the potential for market growth

Overall world revenue for Anti-Infective Vaccines Market will surpass $xx billion in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Anti-Infective Vaccines Market report helps you

In summary, our 370+ page report provides you with the following knowledge:
. Revenue forecasts to 2031 for Anti-Infective Vaccines Market, with forecasts for Product Type, Disease Type, and Distribution Channel, each forecasted at a global and regional level- discover the industry’s prospects, finding the most lucrative places for investments and revenues
. Revenue forecasts to 2031 for 5 regional and 16 key national markets- See forecasts for the Anti-Infective Vaccines market in North America, Europe, Asia Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea, among other prominent economies.
. Prospects for established firms and those seeking to enter the market- including company profiles for 15 of the companies involved in the Anti-Infective Vaccines Market. Some of the company’s profiled in this report include Evotec, Merck & Co, Inc., GlaxoSmithKline plc., Emergent BioSolutions Inc., Valneva SE, CSL Limited, Pfizer, Serum Institute of India Pvt. Ltd., BioDiem, Mitsubishi Tanabe Pharma Corporation, Sinovac Biotech Ltd., Bavarian Nordic, Berna Biotech Pharma GmbH, Hookipa Pharma Inc., and Syneos Health among other prominent players.

Read the full report: https://www.reportlinker.com/p06126789/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting